((自动化翻译由路透提供，请见免责声明 )) Svea Herbst-Bayliss
路透纽约10月22日 - Starboard Value称消费品公司Kenvue 是一个便宜货，并称其皮肤健康和美容部门增长乏力是该股表现不佳的原因。
Starboard 首席投资官杰弗里-史密斯（Jeffrey Smith）说，拥有露得清（Neutrogena）和艾维诺（Aveeno）品牌的该部门有机会提高收入增长和利润率。
史密斯说："他们需要专注于皮肤健康美容，"他开玩笑说，"这听起来很简单，对吧？现在他们只需要做到这一点。
对冲基金已经在这家生产创可贴、李施德林和泰诺的消费品公司建立了相当大的股份。Kenvue 于去年上市，市值约为 440 亿美元。
Kenvue 以前隶属于强生公司 ，自 2023 年 5 月上市以来，股价下跌了 18%。周一的收盘价为每股 22.92 美元。
史密斯在13D Monitor主动-被动投资者峰会上发言。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.